Long before a heart beats or a hand forms, a human body begins as a single cell, and how that one cell branches into the many parts of a person has been among biology's oldest unanswered puzzles. A team spanning the Wellcome Sanger Institute and Cambridge has found a quieter way to read that history: the small mutations cells collect as they divide, which serve as faint handwriting tracing their ancestry. Their findings suggest that the first great divergence, between the embryo proper and the tissues that nourish it, happens earlier than had been assumed, and that human development may not fo
Human Fetal Development Traced to Single Cell: Mutation Study Shifts Timing of Early Cell Fate Decisions
25 mutations by week eight, 42 by week 18
Mark
So what is actually new here? People have studied embryos for a long time.
Mimi
Mostly by looking, or by using animals. Tracing cell family trees in humans needed an approach that doesn't touch the embryo, so the team read mutations as markers instead.
Mark
Where did the cells come from?
Mimi
Blood stem and progenitor cells from human fetal tissue at eight and eighteen weeks, grown into 511 single-cell colonies. Hundreds of those were sequenced.
Luke
Worth saying plainly: the sequencing was of hundreds of colonies, not all 511, and it's blood cells being used to infer the timing for other tissues.
Mark
What did the mutation counts show?
Mimi
Twenty-five mutations by week eight, 42 by week 18. That implies more mutation in the earliest divisions.
Luke
Right, but that's an inference from two time points. The source doesn't give a per-division rate.
Mark
And the fetus-versus-placenta decision?
Mimi
Timed between four and 16 cells, earlier than previously thought. It's a range, not a single stage.
Mark
The mouse difference seems big.
Mimi
The evidence suggests early blood cells arise from the hypoblast in humans, unlike in mice. Chapman says that settles a decades-old debate.
Luke
That's the authors' own framing. Whether the wider field treats it as settled isn't something this reporting can tell us. And the disease link is a stated hope: it's a reference, not yet a finding about any cancer.
El Pulso
- Scientists could not directly trace human embryo cell families, so they turned to the mutations cells quietly accumulate as their natural tracking marks.
- The early decision between becoming the fetus or the placenta appears to occur between the four-cell and sixteen-cell stages, far sooner than textbooks assumed.
- Primitive blood cells seem to arise from the hypoblast, a tissue long considered extra-embryonic, overturning assumptions drawn from mouse models.
- Researchers are now using this mutation reference as a baseline to find where childhood cancers and rare developmental disorders first go wrong in the womb.
Long before a heart beats or a hand forms, a human body begins as a single cell, and how that one cell branches into the many parts of a person has been among biology's oldest unanswered puzzles. A team spanning the Wellcome Sanger Institute and Cambridge has found a quieter way to read that history: the small mutations cells collect as they divide, which serve as faint handwriting tracing their ancestry. Their findings suggest that the first great divergence, between the embryo proper and the tissues that nourish it, happens earlier than had been assumed, and that human development may not follow the mouse script as closely as science once presumed. In the widening record of how life begins, this work offers both a corrected map and a baseline against which the misfortunes of early development can finally be measured.
Researchers at the Wellcome Sanger Institute, the Wellcome-MRC Cambridge Stem Cell Institute and the University of Cambridge set out on a question as old as biology itself: how does a complex human body arise from a single cell? Their route was unusual. Instead of manipulating a developing embryo, which is neither ethical nor possible in people, they read the mutations that cells pick up naturally as they divide.
The team collected blood-forming precursor cells from human fetal tissue at eight and eighteen weeks, grew them into 511 single-cell colonies, and sequenced the DNA of hundreds of them. By matching shared mutations back through the family tree, they could reconstruct the lineage of blood cells to the first division of the embryo, then check other tissues for the same markers to see when each had branched away.
The mutation counts showed that the earliest divisions were the most mutation-prone, and the timing revealed that the split between fetus and placenta or yolk sac occurred between the four- and sixteen-cell stages, much earlier than previously thought. Dr Anna Ranzoni, a first author, said the findings challenge earlier accounts of how the fetus grows from one cell.
The study also found a difference from mice. Evidence suggests the blood cells that carry oxygen in the first trimester arise from the hypoblast, a tissue usually regarded as extra-embryonic. Dr Michael Spencer Chapman of the Sanger Institute noted that mice had long served as a model whose similarity to humans was never certain, and that this finding settles a decades-old debate.
Finally, the work offers a baseline. Childhood cancers and rare developmental disorders often begin before birth, and knowing how mutations normally accumulate in early life is the reference needed to spot when something goes wrong. Dr Ana Cvejic, a senior author, called the resource invaluable. The next step is to use it to study those diseases.
Researchers at the Wellcome Sanger Institute, the Wellcome-MRC Cambridge Stem Cell Institute and the University of Cambridge have taken a new route to an old question: how does a human body, with all its complexity, arise from one cell? Their answer, published in Nature, comes from reading the mutations that cells pick up along the way during pregnancy.
The usual way to map how cells descend from one another is lineage tracing. Cells are marked so that the mark passes to their offspring, and a family tree can be drawn. That method requires manipulating a developing embryo, which is neither ethical nor feasible in humans. As a result, the study of human development has relied mostly on careful microscopy, and much of what is known comes from model organisms such as zebrafish and mice.
The team worked around this by using mutations as natural markers. They collected hematopoietic stem and progenitor cells, the precursors of blood cells, from human fetal tissue at eight weeks and at eighteen weeks of development. These were grown into 511 colonies, each derived from a single cell. DNA from hundreds of the colonies underwent whole genome sequencing to find somatic mutations that could trace the lineage of the blood cells back to the first division of the embryo. The researchers then looked for the same marker mutations in tiny biopsies from other tissues, which showed when those tissues had split off from the blood cell population.
The mutation counts pointed to a pattern. By week eight, cells had acquired 25 mutations, and by week 18 the figure was 42. That is a higher rate of mutation in the earliest cell divisions than later on. The team also timed the early 'decision' over which cells become the fetus and which become extra-embryonic tissue, such as the placenta and yolk sac. It happened between the four-cell and 16-cell stages, much earlier than previously thought.
Dr Anna Ranzoni, a first author from the Cambridge Stem Cell Institute and the university's Department of Haematology, said the findings challenge some earlier understanding of how the fetus grows from one cell, including when embryonic and extra-embryonic tissues diverge. That kind of resolution, she said, will be essential for pinpointing the origins of diseases rooted in development.
The study also turned up a difference between humans and mice. There was evidence that the extra-embryonic mesoderm, and the blood cells that carry oxygen to the fetus in the first trimester, arise from the hypoblast, which is generally regarded as an extra-embryonic tissue. First author Dr Michael Spencer Chapman of the Sanger Institute said mice have been an excellent model, but it was always open whether their biology was the same as ours or merely similar. He said the finding that primitive human blood cells arise from the hypoblast, unlike in mice, settles a question debated for decades.
The work also gives researchers a baseline. Childhood cancers and rare developmental disorders often begin in utero, and a record of how mutations accumulate under normal conditions is the reference needed to recognize when something has gone wrong. Dr Ana Cvejic, a senior author from the Cambridge Stem Cell Institute and the Department of Haematology, said such insights into the earliest weeks of life had not been possible until now, and called the resource invaluable for starting to unravel what happens when development goes awry. The next step is applying that reference to studies of those diseases.
Citas Notables
We found evidence that primitive human blood cells arise from the hypoblast, which is different to mice, settling a question that has been debated for decades.— Dr Michael Spencer Chapman, first author, Wellcome Sanger Institute
This resource will be an invaluable reference for what happens under normal circumstances, so that we can start to unravel what happens when development goes wrong.— Dr Ana Cvejic, senior author, Wellcome-MRC Cambridge Stem Cell Institute
Quieres la nota completa?
Lee el original en News-Medical.net ↗
Science & Space